文献速递生殖医学

孕前抗甲状腺过氧化物酶抗体而非促甲状腺激素与不孕女性活产率降低相关

Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women.
PubMed 文献 · Fertil Steril · 2017-10-25

该研究对两项多中心随机对照试验中1468例不孕女性的血清样本进行二次分析,评估孕前促甲状腺激素(TSH)和抗甲状腺过氧化物酶(TPO)抗体与生殖结局的关系。结果显示TSH≥2.5 mIU/L与不良生殖结局无关,而抗TPO抗体阳性与流产风险升高(比值比2.17)和活产概率降低(比值比0.58)相关。

要点

  • 不孕女性中孕前TSH≥2.5 mIU/L与生殖结局无显著关联。
  • 抗TPO抗体阳性者流产率43.9% vs 25.3%,活产率17.1% vs 25.4%。
  • 校正后抗TPO抗体阳性者流产比值比2.17,活产比值比0.58。

核心结论

  • 不孕女性中孕前TSH≥2.5 mIU/L与不良生殖结局无关,但抗TPO抗体与流产风险增加和活产概率降低相关。

研究设计与样本

  • 对尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所生殖医学网络开展的两项多中心随机对照试验数据进行二次分析,纳入1468例不孕女性的血清样本。

主要发现

  • TSH≥2.5 mIU/L组与TSH<2.5 mIU/L组的受孕率、临床妊娠率、流产率和活产率均无差异。
  • 抗TPO抗体阳性组与阴性组的受孕率分别为33.3%和36.3%。
  • 抗TPO抗体阳性组与阴性组的流产率分别为43.9%和25.3%,活产率分别为17.1%和25.4%。
  • 多因素logistic回归模型校正后,抗TPO抗体阳性者流产比值比为2.17(95%CI 1.12-4.22),活产比值比为0.58(95%CI 0.35-0.96)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study whether preconceptual thyroid-stimulating hormone (TSH) and antithyroid peroxidase (TPO) antibodies are associated with poor reproductive outcomes in infertile women. DESIGN: Secondary analysis of data from two multicenter, randomized, controlled trials conducted by the Reproductive Medicine Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Multivariable logistic regression analyses were performed to assess the association between preconceptual TSH levels and anti-TPO antibodies. SETTING: Not applicable. PATIENT(S): Serum samples from 1,468 infertile women were utilized. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Cumulative conception, clinical pregnancy, miscarriage, and live birth rates were calculated. RESULT(S): Conception, clinical pregnancy, miscarriage, and live birth rates did not differ between patients with TSH ≥2.5 mIU/L vs. TSH < 2.5 mIU/L. Women with anti-TPO antibodies had similar conception rates (33.3% vs. 36.3%) but higher miscarriage rates (43.9% vs. 25.3%) and lower live birth rates (17.1% vs. 25.4%) than those without anti-TPO antibodies. Adjusted, multivariable logistic regression models confirmed elevated odds of miscarriage (odds ratio 2.17, 95% confidence interval 1.12-4.22) and lower odds of live birth (oddr ratio 0.58, 95% confidence interval 0.35-0.96) in patients with anti-TPO antibodies. CONCLUSION(S): In infertile women, preconceptional TSH ≥2.5 mIU/L is not associated with adverse reproductive outcomes; however, anti-TPO antibodies are associated with increased risk of miscarriage and decreased probability of live birth. CLINICAL TRIAL REGISTRATION NUMBER: PPCOS II NCT00719186; AMIGOS NCT01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Seungdamrong A, Steiner AZ, Gracia CR, et al. Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertil Steril. 2017. PMID: 29102040. doi:10.1016/j.fertnstert.2017.08.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。